<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
----------
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)(1)
AVANT IMMUNOTHERAPEUTICS
- --------------------------------------------------------------------------------
(Name of issuer)
COMMON SHARES, PAR VALUE $.001
- --------------------------------------------------------------------------------
(Title of class of securities)
872342 10 0
- --------------------------------------------------------------------------------
(CUSIP number)
NEIL G. CAWSEY; FOREST CITY ENTERPRISES, 1160 TERMINAL TOWER, 50 PUBLIC SQUARE,
CLEVELAND, OHIO 44113; (216) 416-3277
- --------------------------------------------------------------------------------
(Name, address and telephone number of person
authorized to receive notices and communications)
MARCH 10, 2000
- --------------------------------------------------------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1 (e), 13d-1(f) or 13d-1(g), check the
following box [ ].
Note. Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7 for
other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 6 Pages)
- ----------
(1) The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
SCHEDULE 13D
- --------------------------- ------------------------------
CUSIP No. 872342 10 0 13D Page 2 of 6 Pages
---------------- ------- ------
- --------------------------- ------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
FOREST CITY 38 SIDNEY STREET, INC.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS
OO*
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) or 2(e)
[ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
OHIO
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER 1,376,250
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER N/A
OWNED BY ------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER 1,376,250
REPORTING ------------------------------------------------------
PERSON WITH 10 SHARED DISPOSITIVE POWER N/A
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,376,250
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.87%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE> 3
* The consideration used by Forest City 38 Sidney Street, Inc.
(hereafter, "Forest City") in acquiring the Common Shares of Avant
Immunotherapeutics, Inc. (formerly known as T Cell Sciences, Inc.) involved
Forest City's execution of a Settlement Agreement, dated November 14, 1997,
between Forest City and T Cell Sciences, Inc., releasing and discharging alleged
liabilities arising out of Forest City claims under certain leases between
Forest City and T Cell Sciences, Inc.
<PAGE> 4
SCHEDULE 13D
Item 1. Security and Issuer.
(a) Common Shares, par value $.001
(b) Avant Immunotherapeutics, Inc. (hereafter, "Avant")
119 Fourth Avenue
Needham, Massachusetts
Item 2. Identity and Background.
Name: Forest City 38 Sidney Street, Inc.
(hereafter, "Forest City")
State of organization: Ohio
Principal business: Owner and lessor of commercial properties
Principal business address: 1100 Terminal Tower, Cleveland, Ohio, 44113
Principal office address: 1100 Terminal Tower, Cleveland, Ohio, 44113
(d) Not Applicable
(e) Not Applicable
Item 3. Source and Amount of Funds or Other Consideration.
The Common Shares of Avant were acquired by Forest City pursuant
to a Settlement Agreement dated November 14, 1997, (hereafter, the
"Settlement Agreement") between Forest City and T Cell Sciences,
Inc. (predecessor to Avant) in consideration of Forest City's
release and discharge of alleged liabilities arising out of claims
asserted under certain leases.
Item 4. Purpose of the transaction.
As stated in Item 3 above, the purpose of Forest City's acquiring
the Avant Common Shares was to satisfy the Settlement Agreement
executed between T Cell Sciences, Inc. and Forest City.
Item 5. Interest in Securities of the Issuer.
(a) The aggregate number of Common Shares beneficially owned by Forest
City is 1,376,250, which comprises approximately 2.87% of the
outstanding Avant Common Shares.
<PAGE> 5
(b) 1,376,250 Common Shares with sole power to direct the vote.
1,367,250 Common Shares with sole power to direct the disposition.
(c) On March 10, 2000, Forest City sold 57,500 Common Shares of Avant
through a series of open market transactions executed by a
registered broker at an average price of $15.0543 per share.
(d) Not Applicable.
(e) March 10, 2000.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
None.
Item 7. Material to Be Filed as Exhibits.
None.
<PAGE> 6
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
April 11, 2000 FOREST CITY 38 SIDNEY STREET, INC.
/s/ Thomas G. Smith
----------------------------------
By: Thomas G. Smith
Its: Secretary
